2,460
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Use of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia

ORCID Icon, , , , , , , , , , , & show all
Pages 241-249 | Received 27 Jun 2017, Accepted 28 Jul 2017, Published online: 08 Aug 2017

Figures & data

Table 1. Baseline characteristics between BPH participants and control patients.

Table 2. Descriptive statistics of IPSS, SF-12v2 scores and DASS-21 scores at baseline.

Table 3. Corrected item–scale correlation of the IPSS.

Figure 1. ROC curves of IPSS total symptom and HRQOL scores.

Figure 1. ROC curves of IPSS total symptom and HRQOL scores.

Figure 2. Ability of IPSS scores, SF-12v2 scores and DASS-21 scores in discriminating between benign prostatic hyperplasia and control patients by the independent t-test. Error bars indicate mean +/- standard deviation.

Figure 2. Ability of IPSS scores, SF-12v2 scores and DASS-21 scores in discriminating between benign prostatic hyperplasia and control patients by the independent t-test. Error bars indicate mean +/- standard deviation.

Table 4. Responsiveness to change over time from baseline to 6-month follow-up (N = 91).

Table 5. Responsiveness to change over time from baseline to 6-month follow-up among patients with improved health status (N = 27).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.